These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12095698)

  • 1. Effect of the DNA topoisomerase II inhibitor VP-16 on illegitimate recombination in yeast chromosomes.
    Asami Y; Jia DW; Tatebayashi K; Yamagata K; Tanokura M; Ikeda H
    Gene; 2002 May; 291(1-2):251-7. PubMed ID: 12095698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.
    Tsukamoto Y; Kato J; Ikeda H
    Genetics; 1996 Feb; 142(2):383-91. PubMed ID: 8852838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage.
    Malik M; Nitiss KC; Enriquez-Rios V; Nitiss JL
    Mol Cancer Ther; 2006 Jun; 5(6):1405-14. PubMed ID: 16818498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the topoisomerase-II inhibitor etoposide on meiotic recombination in male mice.
    Russell LB; Hunsicker PR; Hack AM; Ashley T
    Mutat Res; 2000 Jan; 464(2):201-12. PubMed ID: 10648907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells.
    Aratani Y; Andoh T; Koyama H
    Mutat Res; 1996 Feb; 362(2):181-91. PubMed ID: 8596537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hdf1, a yeast Ku-protein homologue, is involved in illegitimate recombination, but not in homologous recombination.
    Tsukamoto Y; Kato J; Ikeda H
    Nucleic Acids Res; 1996 Jun; 24(11):2067-72. PubMed ID: 8668537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
    Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.
    Sabourin M; Nitiss JL; Nitiss KC; Tatebayashi K; Ikeda H; Osheroff N
    Nucleic Acids Res; 2003 Aug; 31(15):4373-84. PubMed ID: 12888496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of a chromosomal rearrangement involved in the adaptive evolution of yeast strains.
    Pérez-Ortín JE; Querol A; Puig S; Barrio E
    Genome Res; 2002 Oct; 12(10):1533-9. PubMed ID: 12368245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase I involvement in illegitimate recombination in Saccharomyces cerevisiae.
    Zhu J; Schiestl RH
    Mol Cell Biol; 1996 Apr; 16(4):1805-12. PubMed ID: 8657156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic evidence that DNA topoisomerase II is not involved in radiation induced chromsome-type aberrations.
    Mosesso P; Pepe G; Ottavianelli A; Schinoppi A; Cinelli S
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():14-8. PubMed ID: 26520368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere dysfunction increases mutation rate and genomic instability.
    Hackett JA; Feldser DM; Greider CW
    Cell; 2001 Aug; 106(3):275-86. PubMed ID: 11509177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human topoisomerase I mediates illegitimate recombination leading to DNA insertion into the ribosomal DNA locus in Saccharomyces cerevisiae.
    Zhu J; Schiestl RH
    Mol Genet Genomics; 2004 Apr; 271(3):347-58. PubMed ID: 15007730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression.
    Hashimoto H; Chatterjee S; Berger NA
    Cancer Res; 1995 Sep; 55(18):4029-35. PubMed ID: 7664276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Identification of Determinants for Single-Strand Annealing-Mediated Deletion Formation in
    Segura-Wang M; Onishi-Seebacher M; Stütz AM; Mardin BR; Korbel JO
    G3 (Bethesda); 2017 Oct; 7(10):3269-3279. PubMed ID: 28818866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meiotic interallelic conversion at the human minisatellite MS32 in yeast triggers recombination in several chromatids.
    Appelgren H; Cederberg H; Rannug U
    Gene; 1999 Oct; 239(1):29-38. PubMed ID: 10571031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DNA topoisomerase II in living cells stimulates illegitimate recombination.
    Umanskaya ON; Ioudinkova ES; Razin SV; Bystritskiy AA
    Dokl Biochem Biophys; 2005; 405():423-5. PubMed ID: 16480143
    [No Abstract]   [Full Text] [Related]  

  • 18. Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposide.
    Vassetzky YS; Alghisi GC; Roberts E; Gasser SM
    Br J Cancer; 1996 May; 73(10):1201-9. PubMed ID: 8630279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase II inhibitors enhance random integration of transfected vectors into human chromosomes.
    Fujimaki K; Aratani Y; Fujisawa S; Motomura S; Okubo T; Koyama H
    Somat Cell Mol Genet; 1996 Jul; 22(4):279-90. PubMed ID: 9000172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae.
    Tsukamoto Y; Kato J; Ikeda H
    Nature; 1997 Aug; 388(6645):900-3. PubMed ID: 9278054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.